Abstract
A new method for concentrated ascitic fluid reinfusion using a double ultrafiltration device is reported as 22 procedures in 20 cirrhotic patients (6 females, 14 males; median age 55 years, range 33–69) with tense, refractory ascites. Eight of the 20 patients had elevated creatinine levels. The mean time for each procedure was 189±82 min, during which a mean of 7.7 liters (1.3–13.3) of ultrafiltered ascitic fluid was removed and 613 ml (140–1700) of concentrated ascitic fluid rich in albumin (mean: 60 g, range 14–175) was reinfused. The procedure resulted in a mean weight loss of 8.1 kg (2.2–14.0) and a mean increase of 163 ml in urine output (24 hr). A reduction in the serum creatinine level (P<0.05) and an increase in the plasma atrial natriuretic factor level (P<0.02) 24 hr after reinfusion, while no changes in serum albumin, plasma and urinary electrolytes, plasma renin activity, aldosterone, and antidiuretic hormone levels were noted. Although minor evidence for a disturbance in coagulation was observed, there were no episodes of clinical bleeding. Four patients (20%) had transient chills or fever. Based upon this experience, it can be concluded that reinfusion of cascade filtrated and concentrated ascitic fluid is a rapid, safe, and effective treatment for patients with tense ascites; it appears to have less side effects than more traditional methods and importantly does not require administration of heterologous plasma derivatives.
Similar content being viewed by others
References
Sherlock S: Disease of the Liver and Biliary System, 7th ed. Oxford, Blackwell, 1985
Conn HO: The rational management of ascites.In Progress in Liver Diseases. H Popper, F Schaffner (eds). New York, Grune and Stratton, 1972, pp 269–288
Starzl TE, Demetris AJ, Van Thiel DH: Liver transplantation (parts 1 and 2). N Engl J Med 321:1014–1022, 1092–1099, 1989
Schiff E: Paracentesis: A safe and effective form of therapy. Hepatology 7:591–593, 1987
Kao HW, Rakov NE, Savage E, Reynolds TB: The effect of large volume paracentesis on plasma volume. A cause of hypovolemia? Hepatology 5:403–407, 1985
Gines P, Arroyo V, Quintero E, Planas R, Bory F, Cabreara J, Rimola A, Viver J, Camps J, Jimenex W, Mastai R, Gaya J, Rodes J: Comparison between paracentesis and diuretics in the treatment of cirrhotics with tense ascites. Gastroenterology 93:234–241, 1987
Salerno F, Badalamenti S, Incerti PL, Tempini S, Restelli B, Bruno S, Bellati G, Roffi L: Repeated paracentesis and IV albumin infusion to treat tense ascites in cirrhotic patients. A safe alternative therapy. J Hepatol 5:102–108, 1987
Martin A, Rossaro L, Sturniolo GC, Naccarato R: Treatment of refractory ascites by concentrated ascitic fluid reinfusion.In Assessment and Management of Hepatobiliary Disease. L Okolicsanyi, G Cosmos, G Crepaldi (eds). Berlin, Springer, 1987, pp 303–307
Valbonesi M, Torre GC, Capra C, Frisoni R, Testa R, Zia S, Ferrari M: Reverse cascase filtration of ascites fluid—preliminary results. Int J Artif Organs 11:134–138, 1988
Tito L, Gines P, Arroyo V, Planas R, Panes J, Rimola A, Llach J, Humbert P, Badalamenti S, Jimenez W, Rodes J: Total paracentesis associated with intravenous albumin management of patients with cirrhosis and ascites. Gastroenterology 98:146–151, 1990
Planas R, Gines P, Arroyo V, Llach J, Panes J, Vargas V, Aslmeron JM, Gines A, Toledo C, Rimola A, Jimenez W, Asbert M, Gassul MA, Rodes J: Dextran-70 versus albumin as plasma expanders in cirrhotic patients with tense ascites treated with total paracentesis: Results of a randomized trial. Gastroenterology 99:1736–1744, 1990
Salerno F, Badalamenti S, Lorenzano E, Moser P, Incerti PL: Randomized comparative study of hemaccel vs albumin infusion after total paracentesis in cirrhotic patients with refractory ascites. Hepatology 13:707–713, 1991
Le Veen HH, Browne T, D'Ovidio NG: Surgical treatment of ascites.In Advances in Surgery. GL Jordan (ed). Chicago, Year Book Publishers, 1980, pp 107–150
Smajda C, Franco D: The LeVeen shunt in the elective treatment of intractable ascites in cirrhosis: A prospective study in 140 patients. Ann Surg 201:488–493, 1985
Greig PD, Blendis LM, Langer B, Taylor BR, Colapinto FR: Renal and hemodynamic effects of the peritoneovenous shunt II. Long-term effects. Gastroenterology 80:119–125, 1981
Wilkinson SP, Handerson J, Davidson AR, Williams R: Ascites reinfusion using the rhodiascit apparatus—clinical experience and coagulation abnormalities. Postgrad Med J 51:583–587, 1975
Smart HL, Triger DR: A randomized prospective trial comparing daily paracentesis and intravenous albumin with recirculation in diuretic refractory ascites. J Hepatol 10:191–197, 1990
Rubinstein D, McInnes I, Dudley F: Morbidity and mortality after peritoneovenous shunt surgery for refractory ascites. Gut 26:1070–1073, 1985
Wilde JT, Cooper P, Kennedy HJ, Triger DR, Preston FE: Coagulation disturbances following ascites recirculation. J Hepatol 10:217–222, 1990
Bories P, Garcia Compean D, Michel H, Bowiel M, Capron JP, Gauthier A, Lafon J, Lévy VG, Pascal JP, Quinton A, Toumieux B, Weill JP: The treatment of refractory ascites by the LeVeen shunt: A multi-centre controlled trial (57 patients). J Hepatol 3:212–218, 1986
Scholtz DG, Nagorney DM, Lindor KD: Poor outcome from peritoneovenous shunts for refractory ascites. Am J Gastroenterol 84:540–543, 1989
Wormser GP, Hubbard RD: Peritonitis in cirrhotic patients with LeVeen shunts. Am J Med 71:358–362, 1981
Gines P, Arroyo V, Vargas V, Planas R, Casafont F, Panes J, Hoyos M, Viladomiu L, Rimola A, Morillas R, Salmeron JM, Gines A, Esteban R, Rodes J: Paracentesis with intravenous infusion of albumin as compared with peritovenous shunting in cirrhosis with refractory ascites. N Engl J Med 325:829–835, 1991
Campbell PJ, Skorecki KL, Logan AG, Wong PY, Leung WM, Greig P, Blendis LM: Acute effects of peritoneovenous shunting on plasma atrial natriuretic peptide in cirrhotic patients with massive refractory ascites. Am J Med 84:112–119, 1988
Epstein M, Loutzenhiser R, Norsk P, Atlas S: Relationship between plasma ANF responsiveness and renal sodium handling in cirrhotic humans. Am J Nephrol 9:133–143, 1989
Salerno F, Badalamenti S, Moser P, Lorenzano E, Incerti PL, Dioguardi N: Atrial natriuretic factor in cirrhotic patients with tense ascites. Effect of large-volume paracentesis. Gastroenterology 98:1063–1070, 1990
Patrassi GM, Martinelli S, Sturniolo GC, Cappellato MG, Vicariotto M, Girolami A: Fibrinolytic study in plasma and ascitic fluid of cirrhotic patients before and after ascites concentration. Reinfusion technique. Eur J Clin Invest 15:161–165, 1985
Patrassi GM, Sartori MT, Sgarabotto D, Sturniolo G, Boeri G, Girolami A: A DIC-like picture on plasma and ascitic fluid of cirrhotic patients. Res Exp Med 188:351–356, 1988
Smart HL, Triger DR: Long term survival following the treatment of refractory ascites with the Rhodiascit apparatus. J Clin Nutr Gastroenterol 3:10–14, 1988
Conn HO, Lieberthal MM: The Hepatic Coma Syndromes and Lactulose. Baltimore, Williams and Wilkins, 1979
Author information
Authors and Affiliations
Additional information
This study was done under the auspices of the R. Farini Foundation for Gastroenterological Research.
Rights and permissions
About this article
Cite this article
Rossaro, L., Graziotto, A., Bonato, S. et al. Concentrated ascitic fluid reinfusion after cascade filtration in tense ascites. Digest Dis Sci 38, 903–908 (1993). https://doi.org/10.1007/BF01295918
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01295918